- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 14, 2023
Product Development
Sanofi’s shifting shape of R&D during Reed’s tenure
As R&D head John Reed departs for a new gig at J&J, Sanofi remains in the midst of a transition
BioCentury | Nov 3, 2022
Deals
Nov. 2 Quick Takes: CSL paying $200M for Arcturus’ mRNA vaccine tech
Plus Rubius seeking alternatives and updates from Horizon, Lilly-Innovent, GSK, Compass, Regeneron, Exelixis, CFIUS and more
BioCentury | Nov 12, 2021
Product Development
Dip in Tagrisso growth mars bright spots ahead for AZ
U.K. pharma planning to price COVID vaccine at profit, datopotamab enters new Phase III
BioCentury | Jun 4, 2019
Distillery Techniques
Gemcitabine, Jevtana and Jakavi identified to treat pediatric AML
BioCentury | Apr 26, 2019
Company News
European regulatory roundup: CHMP opinions and a Portola approval
Items per page:
1 - 10 of 58